The Rise of Biosimilars in IBD Treatment
Biologics have transformed Crohn's disease treatment, but they are expensive. Biosimilars — highly similar versions of biologics — are changing that. They offer comparable efficacy and safety at lower cost, improving access for patients. In inflammatory bowel disease, biosimilars are becoming an important part of the treatment landscape, and the market is responding. Biosimilars are...
0 Kommentare 0 Geteilt 253 Ansichten 0 Bewertungen